Oct 8 (Reuters) - U.S. FDA:
* FDA SAYS IS REISSUING MAY 26, 2021 LETTER IN ITS ENTIRETY, TO REFLECT THAT DISTRIBUTION OF AUTHORIZED SOTROVIMAB WILL BE CONTROLLED BY U.S. GOVERNMENT Source text for Eikon: Further company coverage:
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.02 USD | -0.74% | +0.25% | +0.55% |
Oct 8 (Reuters) - U.S. FDA:
* FDA SAYS IS REISSUING MAY 26, 2021 LETTER IN ITS ENTIRETY, TO REFLECT THAT DISTRIBUTION OF AUTHORIZED SOTROVIMAB WILL BE CONTROLLED BY U.S. GOVERNMENT Source text for Eikon: Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+0.55% | 1.36B | |
+8.90% | 45.97B | |
+52.62% | 43.93B | |
+9.95% | 42.34B | |
-8.59% | 28.27B | |
+17.25% | 27.18B | |
-20.27% | 19.44B | |
+14.26% | 13.83B | |
+31.67% | 12.4B | |
+8.61% | 11.45B |